ATE346036T1 - Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen - Google Patents
Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungenInfo
- Publication number
- ATE346036T1 ATE346036T1 AT99924434T AT99924434T ATE346036T1 AT E346036 T1 ATE346036 T1 AT E346036T1 AT 99924434 T AT99924434 T AT 99924434T AT 99924434 T AT99924434 T AT 99924434T AT E346036 T1 ATE346036 T1 AT E346036T1
- Authority
- AT
- Austria
- Prior art keywords
- arthritis
- cancer
- treatment
- retinal diseases
- antiangiogenic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8406398A | 1998-05-22 | 1998-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE346036T1 true ATE346036T1 (de) | 2006-12-15 |
Family
ID=22182661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99924434T ATE346036T1 (de) | 1998-05-22 | 1999-05-21 | Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1080070B1 (de) |
JP (1) | JP4554816B2 (de) |
AT (1) | ATE346036T1 (de) |
CA (1) | CA2332535C (de) |
CY (1) | CY1105977T1 (de) |
DE (1) | DE69934113T2 (de) |
DK (1) | DK1080070T3 (de) |
ES (1) | ES2276519T3 (de) |
PT (1) | PT1080070E (de) |
WO (1) | WO1999061406A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6632961B1 (en) | 1998-05-22 | 2003-10-14 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
EP1463505A2 (de) * | 2001-12-13 | 2004-10-06 | Abbott Laboratories | 3-(phenyl-alkoxy)-5-(phenyl)-pyridin derivative und verwandte verbindungen als kinase-hemmer zur behandlung von krebs |
US7592466B2 (en) | 2003-10-09 | 2009-09-22 | Abbott Laboratories | Ureas having antiangiogenic activity |
WO2005035524A1 (en) * | 2003-10-09 | 2005-04-21 | Abbott Laboratories | Pyrrolidinyl urea derivatives as angiogensis inhibitors |
WO2006074501A1 (en) | 2005-01-13 | 2006-07-20 | University Of Wollongong | Peptidic compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1922205A (en) * | 1932-01-26 | 1933-08-15 | Squibb & Sons Inc | 2-carboxy-5-amino diphenyl |
GB1498996A (en) * | 1975-10-09 | 1978-01-25 | Hidaka H | Omega-aminoalkanoic acid arylamides |
IT1050750B (it) * | 1975-12-05 | 1981-03-20 | Erba Carlo Spa | Derivati della 3.4 di idro chinazolina |
US4147802A (en) * | 1978-03-17 | 1979-04-03 | Stanley Drug Products, Inc. | Method of treating bacterial infections |
EP0183271B1 (de) * | 1984-11-30 | 1990-05-16 | Shosuke Okamoto | Lysinderivat und Proteinase-Inhibitor |
US5238652A (en) * | 1990-06-20 | 1993-08-24 | Drug Screening Systems, Inc. | Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques |
GB9200415D0 (en) * | 1992-01-09 | 1992-02-26 | Bagshawe Kenneth D | Inactivation of cytotoxic drugs |
ZA935617B (en) * | 1992-08-14 | 1994-03-07 | Akzo Nv | Antiprogestogen containing contraceptives. |
-
1999
- 1999-05-21 DE DE69934113T patent/DE69934113T2/de not_active Expired - Lifetime
- 1999-05-21 JP JP2000550816A patent/JP4554816B2/ja not_active Expired - Lifetime
- 1999-05-21 WO PCT/US1999/011309 patent/WO1999061406A2/en active IP Right Grant
- 1999-05-21 PT PT99924434T patent/PT1080070E/pt unknown
- 1999-05-21 EP EP99924434A patent/EP1080070B1/de not_active Expired - Lifetime
- 1999-05-21 DK DK99924434T patent/DK1080070T3/da active
- 1999-05-21 CA CA002332535A patent/CA2332535C/en not_active Expired - Lifetime
- 1999-05-21 ES ES99924434T patent/ES2276519T3/es not_active Expired - Lifetime
- 1999-05-21 AT AT99924434T patent/ATE346036T1/de active
-
2007
- 2007-02-01 CY CY20071100142T patent/CY1105977T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002516303A (ja) | 2002-06-04 |
CA2332535C (en) | 2006-02-28 |
EP1080070B1 (de) | 2006-11-22 |
WO1999061406A2 (en) | 1999-12-02 |
DE69934113D1 (de) | 2007-01-04 |
DK1080070T3 (da) | 2007-02-26 |
CA2332535A1 (en) | 1999-12-02 |
DE69934113T2 (de) | 2007-06-06 |
CY1105977T1 (el) | 2011-04-06 |
WO1999061406A3 (en) | 2000-01-27 |
EP1080070A2 (de) | 2001-03-07 |
ES2276519T3 (es) | 2007-06-16 |
PT1080070E (pt) | 2007-02-28 |
JP4554816B2 (ja) | 2010-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003018D0 (no) | Triazinangiogenese-inhibitorer | |
MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
MXPA05002420A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos. | |
BR0015911A (pt) | Derivados de benzoimidazole úteis como agentes antiproliferativos | |
DE602004030222D1 (de) | 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen | |
MY136718A (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
MXPA05012196A (es) | Compuestos de isoxazol e isotiazol para el tratamiento de trastornos neurodegenerativos. | |
ATE399758T1 (de) | Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten | |
DE69933885D1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
ATE402150T1 (de) | Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen | |
ATE346036T1 (de) | Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen | |
MXPA04000805A (es) | Peptidos que tienen actividad antiangiogenica. | |
TW200730177A (en) | 4 anilino-3-quinolinecarbonitriles for the treatment of cancer | |
TW200510351A (en) | Oxazole compounds for the treatment of neurodegenerative disorders | |
NO20032411D0 (no) | Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens | |
DK1212315T3 (da) | Nye chalconer | |
DE60219680D1 (de) | Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit | |
ATE271384T1 (de) | Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen | |
ATE327240T1 (de) | 2ß OXO-VORUSCHARIN UND DERIVATEN | |
ATE263556T1 (de) | Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1080070 Country of ref document: EP |